I am a medical physicist with interests in improving the outcome of radiation therapy in treatment of cancer. In particular, we are interested in prediction of outcome of radiation therapy and specifically, stereotactic radiation. Image-guided radiation therapy and extraction of features in images (CT/MRI/PET) using Radiomic features are our current focus.
Ganesh Narayanasamy, Ph.D.
Mayumi Nakagawa, M.D. Ph.D.
Cell-mediated immunity against human papillomavirus (HPV), HPV therapeutic vaccine development, cancer immunotherapy
Shengyu Mu, M.D., Ph.D.
The primary interest of my research has been focusing on the pathogenesis of hypertension in renal salt-reabsorption and the systemic vasculature. The long-term goal of our laboratory is to understand the mechanism of the development of hypertension and to translate our basic scientific discovery to clinics to contribute to a final cure for hypertension.
Dana Moser, Ph.D.
Roy Morello, Ph.D.
We utilize genetically modified mouse models to understand the function of poorly characterized genes that have a function in skeletal development, homeostasis or disease. A special interest is in proteins that post-translationally modify collagens and in osteogenesis imperfecta.
Jeffery Moran, Ph.D.
My research efforts focus on developing new metabolomic approaches which can help us better understand adverse drug reactions and provide new therapeutic strategies. Currently, we are studying phase I and II metabolism of warfarin and applying this information to clinical applications by trying to understand the relationship between warfarin metabolism and anticoagulant therapy outcomes.